Should Diabetes Be Covered By Health Insurance?

Should Diabetes Be Covered by Health Insurance?

Should Diabetes Be Covered by Health Insurance?
Blaming patients for diabetes took a dangerous turn last week. Mick Mulvaney, Director of the Office of Management and Budget (OMB), said that diabetes should not be covered by health insurance.
Responding to a question about insurance, he stated That doesnt mean that we should take care of the person who sits at home, eats poorly and gets diabetes. Is that the same thing as Jimmy Kimmels kid [who was born with a pre-existing heart condition]? I dont think that it is.
The Democratic news website ShareBlue commented, Under Mulvaneys standard , an examination of [people with diabetes] eating habits and how their disease was triggered would have to be undertaken before it could be determined whether they are deserving of health insurance or not. In the meantime, people will suffer and possibly die from their illness.
Mulvaneys views may or may not wind up being incorporated in the new health-care plan just passed by the House of Representatives, but the ignorance didnt start with Trumpcare. Blaming people with Type 2 diabetes for their illness has long been mainstream opinion, which often spills over onto people with Type 1.
The American Diabetes Association (ADA) issued a strong statement that they were disappointed and saddened by Mulvaneys words.
Mr. Mulvaneys comments perpetuate the stigma that one chooses to have diabetes based on his/her lifestyle, ADA wrote. All of the scientific evidence indicates that diabetes develops from a diverse set of risk factors, genetics being a primary cause Nobody should be denied cove Continue reading

Rate this article

Total 1 ratings

Diabetes continues its relentless rise

HealthDay Reporter
(HealthDay News) -- Two new studies on diabetes deliver good and bad news, but the overall message is that the blood sugar disease remains a formidable public health burden.
The first study looked at the incidence of type 1 and type 2 diabetes in U.S. children, and uncovered this troubling trend: From 2002 to 2012, the rates for both types of diabetes increased, especially among racial and ethnic minorities.
But a bit of hope was offered up in the second study: Swedish researchers reported a drop in the incidence of heart disease and stroke in adults with both types of diabetes.
"These studies highlight our concerns about the increasing prevalence of diabetes. Every 23 seconds, another person is diagnosed with diabetes [in the United States]," said Dr. William Cefalu, chief scientific, medical and mission officer for the American Diabetes Association (ADA).
Cefalu added that the Swedish study was encouraging and shows that things are "trending in the right direction. Because of research in diabetes, we've been able to improve the lives of millions of people with diabetes around the world, but the disease is still increasing worldwide. We still have a lot of work to do."
In the United States, approximately 29 million people have diabetes, according to the ADA. The vast majority of those have type 2 diabetes. About 1.3 million people have type 1 diabetes.
In people with type 2 diabetes, the body doesn't use insulin properly. This is called insulin resistance. Insulin is a hormone that helps usher sugar from foods into the body's cells to be used as fuel. Wh Continue reading

New study finds that sitting for protracted periods increases the risk of diabetes, heart disease and death

Latest news from Loughborough University
A new study led by the University of Leicester, in association with colleagues at Loughborough University, has discovered that sitting for long periods increases your risk of diabetes, heart disease and death.
The study combined the results of 18 studies and included a total of 794,577 participants. It was led by Dr Emma Wilmot, a research fellow in the Diabetes Research Group at the University of Leicester, and carried out in collaboration with colleagues from the National Institute for Health Research (NIHR) Leicester – Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit.
According to the study, those who sit for long periods have a two fold increase in their risk of diabetes, heart disease and death. Importantly, associations were independent of the amount of moderate-to-vigorous physical activity undertaken, suggesting that even if an individual meets typical physical activity guidelines, their health may still be compromised if they sit for long periods of time throughout the day.
Dr Wilmot, a Clinical Research Fellow in Diabetes and Endocrinology based at the Leicester Diabetes Centre, Leicester General Hospital, said: “The average adult spends 50-70% of their time sitting so the findings of this study have far reaching implications. By simply limiting the time that we spend sitting, we may be able to reduce our risk of diabetes, heart disease and death.
“Our study also showed that the most consistent associations were between sitting and diabetes. This is an important message because people with r Continue reading

The case for preventing diabetes over cure ― David Heber

NOVEMBER 14 ― As we mark World Diabetes Day today, it is timely to review the fight against diabetes, especially in Singapore.
“If you look at yourself, and at the person sitting to your left, person sitting to your right, most probably at least one of you will have diabetes one day,” said Prime Minister Lee Hsien Loong at the National Day Rally in August.
According to the International Diabetes Foundation (IDF), Singapore has one of the highest incidences of diabetes among developed countries, trailing behind only the United States. One in nine Singaporeans aged between 20 and 79 are diabetic, and this number increases further with age, with three in 10 Singaporeans aged over 60 suffering from the disease.
While worrying, these findings are hardly surprising, as Singaporeans have become more sedentary and less active over time, just like other high-income countries.
And contrary to popular belief, the more common type of diabetes is Type 2 diabetes ― a lifestyle disease arising from poor diets and the lack of exercise.
This marks a stark contrast against the cause of Type 1 diabetes ― an auto-immune condition where the body becomes resistant to insulin and loses its ability to produce enough insulin, leading to high blood sugar levels.
Type 1 diabetes is also largely believed to have genetic links, but the underlying cause still baffles scientists and researchers today.
In fact, over 90 per cent of diabetics suffer from Type 2 diabetes, which develops over a two to 10 year period after high levels of blood sugar are recorded.
Studies done at multiple US centres a Continue reading

Type 1 Diabetes Market Size Worth USD 25.52 Billion By 2024: Hexa Research

Sedentary lifestyles, unhealthy diet habits coupled with rising obesity rates will further enhance the uptake of various types of insulin for the treatment of this disorder. Though this type of diabetes is rare still the number of cases is increasing by 3% every year according to the data enumerated by the International Diabetes Federation (IDF).
Insulin therapy is very much essential in the patients who have type 1 diabetes. Rising launch of the novel insulin formulations along with several adjunct therapies will positively impact the insulin acceptance. On the other hand, this chronic disorder poses a significant economic impact owing to the increasing cost of insulin coupled with other conditions such as cardiac disorders, kidney disease among others. This affects the respective countries and their national healthcare systems. For instance, the expenditure on diabetes management accounts for around 5% to 20% of the total healthcare spending.
Browse full research report with TOC on "Type 1 Diabetes (T1D) Market Size and Forecast, By Insulin Analog (rapid Acting, long Acting, Premix Analogs), And Trend Analysis, 2014 - 2024" at: https://www.hexaresearch.com/research-report/type-1-diabetes-t1d-market
Rapid-acting, long-acting and premix analogs are the three major types of insulin analogs administered to the patients. These insulin types when delivered duplicate the action of natural insulin and avoid the excess release of glucose in blood cells. The market penetration of long-acting insulin products is higher as compared to other two types, however, during the forecast per Continue reading